The TNPO2 Foundation is a patient-first collaborative nonprofit dedicated to changing the way our medical system approaches ultra-rare disease diagnosis and treatment. 

 

Led by caregivers, advocates, and expert scientists, we aim to drive systemic change to make the treatment of rare diseases more navigable, affordable, scalable, and equitable. 

 

The primary focus of our work is using AI and other emergent technologies to advance the development and use of precision treatment for ultra-rare conditions — and to link early diagnosis directly to novel treatments, in a sustainable and equitable way.